In the last trading session, 1.38 million shares of the Pliant Therapeutics Inc (NASDAQ:PLRX) were traded, and its beta was 1.07. Most recently the company’s share price was $12.32, and it changed around -$0.11 or -0.88% from the last close, which brings the market valuation of the company to $725.21M. PLRX currently trades at a discount to its 52-week high of $19.62, offering almost -59.25% off that amount. The share price’s 52-week low was $10.22, which indicates that the current value has risen by an impressive 17.05% since then. We note from Pliant Therapeutics Inc’s average daily trading volume that its 10-day average is 0.47 million shares, with the 3-month average coming to 385.13K.
Pliant Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended PLRX as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pliant Therapeutics Inc (NASDAQ:PLRX) trade information
Instantly PLRX has showed a red trend with a performance of -0.88% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 14.68 on recent trading dayincreased the stock’s daily price by 16.08%. The company’s shares are currently down -31.97% year-to-date, but still down -15.09% over the last five days. On the other hand, Pliant Therapeutics Inc (NASDAQ:PLRX) is -18.95% down in the 30-day period. We can see from the shorts that 7.22 million shares have been sold at a short interest cover period of 17.04 day(s).
The consensus price target as assigned by Wall Street analysts is $40, which translates to bulls needing to increase their stock price by 69.2% from its current value. Analyst projections state that PLRX is forecast to be at a low of $32 and a high of $48.
Pliant Therapeutics Inc (PLRX) estimates and forecasts
Pliant Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -18.52 percent over the past six months and at a -32.73% annual growth rate that is well below the industry average of 17.50%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -22.68%.
PLRX Dividends
Pliant Therapeutics Inc’s next quarterly earnings report is expected to be released in December.
Pliant Therapeutics Inc (NASDAQ:PLRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.86% of Pliant Therapeutics Inc shares, and 111.68% of them are in the hands of institutional investors. The stock currently has a share float of 114.97%. Pliant Therapeutics Inc stock is held by 231.0 institutions, with DEEP TRACK CAPITAL, LP being the largest institutional investor. By 2024-06-30, it held 9.9238% of the shares, which is about 5.97 million shares worth $64.2 million.
BLACKROCK INC., with 8.2612% or 4.97 million shares worth $53.45 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
